| Girish Naganathan |
Girish Naganathan is currently the Chief Technology Officer & Executive VP at DexCom, Inc. He previously worked as the Chief Technology Officer & General Manager at Technicolor, Inc. Naganathan has a graduate degree from Purdue University, an MBA from The University of Colorado, and an undergraduate degree from PSG College of Technology. |
| Teri Lawver |
Teri Lawver is currently the Chairman at Episcopal Relief & Development Corp., the Chief Commercial Officer & Executive VP at DexCom, Inc., and a Trustee at New Jersey Symphony Orchestra. In the past, she has worked as a Director at Episcopal Relief & Development Corp., a Principal at Centocor, Inc., a Vice President-Immunology at Johnson & Johnson, a General Manager at Animas LLC, an Associate Principal at McKinsey & Co., Inc., and a Derivatives Analyst at Bloomberg, Inc. Ms. Lawver has an undergraduate degree from Georgetown University and an MBA from The Fuqua School of Business. |
| Jacob S. Leach |
Jacob S. Leach is currently an Independent Director at SenesTech, Inc. since 2020. He is also currently serving as the Chief Operating Officer & Executive Vice President at DexCom, Inc. since 2004. Previously, he worked at MiniMed, Inc. as the Head of Research & Development from 1996 to 2004. Mr. Leach completed his undergraduate degree at the University of California, Los Angeles. |
| Jereme M Sylvain |
Jereme M Sylvain is currently the Chief Financial Officer & Executive Vice President at DexCom, Inc. Prior to his current position, he held the role of Chief Accounting Officer, VP & Controller at NuVasive, Inc. from 2016 to 2018. He also worked as a Senior Director-Finance at Thermo Fisher Scientific, Inc. in 2014. Mr. Sylvain completed his graduate degree at the University of Notre Dame and his undergraduate degree at Arizona State University. |
| Shelly R. Selvaraj |
Shelly R. Selvaraj is currently working as the Chief Information Officer & Senior Vice President at DexCom, Inc. He started this position in 2021. Prior to his current role, he has a graduate degree from Arizona State University and an undergraduate degree from the University of Madras. |
| Barry J. Regan |
Barry J. Regan is currently the Executive Vice President-Global Operations at DexCom, Inc. He also holds the position of Vice President-Risk Management & Claims at Eastern Dentists Insurance Co. and Senior Vice President-Operations at Wright Medical Group NV. Previously, Mr. Regan worked as the Director at the Pharmaceutical Industry Association of Puerto Rico. He was also a Principal at Commercial Union Insurance Co. and Vice President-Global Operations at Wright Medical Group, Inc. Additionally, he served as Vice President-US & Puerto Rico Operations at AbbVie, Inc. and Senior VP-Global Supply Chain & Procurement at Smith + Nephew, Inc. He held the position of Principal at The St. Paul Cos., Inc.Mr. Regan completed his undergraduate degree at the University of Limerick and earned an MBA from Lake Forest Graduate School of Management. |
| Steven Robert Pacelli |
As the Executive Vice President and Managing Director of Dexcom Ventures, Steve focuses on investment opportunities in sensing technology, data analytics, remote patient monitoring, and population health. His efforts broaden and reiterate the Dexcom commitment to advancing better healthcare outcomes. |
| Andrew K. Balo |
Andrew K. Balo is currently the EVP-Global Medical Affairs, Access & Evidence at DexCom, Inc. Prior to his current position, he held the role of Vice President-Regulatory & Clinical Affairs at Post-Hypothermia Corp. from 1999 to 2002. He also served as the Vice President-Rgulatory & Clinical Affairs at Endocardial Solutions, Inc. Additionally, Mr. Balo was the VP-Quality, Regulatory & Clinical Affairs at St. Jude Medical LLC from 1990 to 1997. He completed his undergraduate degree at the University of Maryland. |
| Donald M. Abbey |
Donald M. Abbey is currently an Independent Director at ICU Medical, Inc. since 2018 and an Executive VP-IT Quality & Regulatory Affairs at DexCom, Inc. since 2016. Previously, he worked as a Director-Quality Assurance at Heartstream, Inc. He also held positions at Becton, Dickinson & Co. as a Senior Vice President-Quality & Regulatory from 2015 to 2016, at Cardinal Health, Inc. as a Senior VP-Quality & Regulatory Affairs from 2007 to 2009, at Protocol Systems, Inc. as a VP-Regulatory Affairs & Quality Assurance, at Respironics, Inc. as a VP-Regulatory Affairs & Quality Assurance from 2006 to 2007, at Welch Allyn, Inc. as a General Manager-Cardiopulmonary Business, and at CareFusion Corp. as an Executive VP-Regulatory & Medical Affairs from 2011 to 2016. Mr. Abbey holds an MBA degree from the University of Washington and an undergraduate degree from Washington State University. |
| Sadie M Stern |
Sadie M Stern is an Independent Director at Sonendo, Inc. and the Chief Human Resources Officer & Executive VP at DexCom, Inc. He previously worked as a Senior Director-Human Resources at QUALCOMM, Inc. from 2012 to 2017 and as an Executive Vice President-People & Culture at 3D Systems Corp. from 2017 to 2020. Stern has an undergraduate degree from San Diego State University and a graduate degree from the University of Denver. |
| Michael Jon Brown |
Michael Jon Brown is currently the Managing Director at Paramount Law Group, Director at Riding On Insulin, and Principal at Stradling, Yocca Carlson & Rauth PC. He is also the Chief Legal Officer & Executive Vice President at DexCom, Inc. starting in 2022. Previously, he worked as an Attorney-Corporate Law Department at Solomon Ward Seidenwurm & Smith LLP, Secretary at Nventa Biopharmaceuticals Corp., Partner at Stradling, Yocca Carlson & Rauth PC, Attorney-Corporate Law Department at Gray Cary Ware & Freidenrich LLP, Attorney-Corporate Law Department at Venture Law Group, and Partner at DLA Piper LLP (United States). He received his undergraduate degree from the University of Washington and his graduate degree from the University of Virginia School of Law. |
| Kevin Ronald Sayer |
Kevin Ronald Sayer is currently the Chairman, President & Chief Executive Officer at DexCom, Inc. since 2018. He is also currently serving as the Director at Medical Device Innovation Consortium since 2021. Previously, he held positions as the Chief Financial Officer at MiniMed, Inc. from 1994 to 2001, Chief Financial Officer & Executive Vice President at Specialty Laboratories, Inc. from 2004 to 2005, Chief Financial Officer & Secretary at Biosensors International Group Ltd. from 2007 to 2010, and Vice President & General Manager at Medtronic MiniMed, Inc. from 2001 to 2002. Mr. Sayer has an undergraduate and graduate degree from Brigham Young University. |
| Steven R. Altman |
Steven R. Altman is the founder of Prospector Capital Corp. (2020). He is currently an Independent Director at DexCom, Inc. (since 2013), a Director at Brain Corp. (US) (since 2016), and a Director at Amionx, Inc., Course Key, Inc., Yembo, Inc., The Salk Institute for Biological Studies, and Managing Member at AJL Investments LLC. Mr. Altman's former positions include Vice Chairman at QUALCOMM, Inc. (1989-2014), Chairman at Prospector Capital Corp., Director at Amylin Pharmaceuticals, Inc. (2006-2010), Director at ViaCyte, Inc., Director at JDRF International, Director at CONNECT, Independent Director at Ubiquiti, Inc. (2013-2015), and President at QTL Biosystems LLC (2000-2005). Mr. Altman received his undergraduate degree from Northern Arizona University in 1983 and his graduate degree from the University of San Diego School of Law in 1986. Mr. Altman is also the founder of Local Music LLC. |
| Nicholas Augustinos |
Nicholas Augustinos is currently the Chairman at Aver, Inc. since 2019. He is also an Independent Director at DexCom, Inc. since 2009 and an Adviser at California HealthCare Foundation since 2015. Previously, he held positions such as Senior Director-Global Healthcare Operations at Cisco Systems, Inc. from 2005 to 2011, Director at Continua Health Alliance in 2010, Director at Rally Health, Inc. from 2012 to 2014, Director at The SCAN Foundation from 2011 to 2014, Director at Audax Health Solutions LLC from 2012 to 2014, and SVP-Health Information Services & Strategy at Cardinal Health, Inc. from 2011 to 2015. He also served as Vice President at Emdeon Corp. from 1998 to 2000, Vice President-Care Data Exchange at CareScience, Inc. from 2002 to 2004, and Vice President at WebMD Health Corp. from 1998 to 2000. Additionally, he worked as a Partner at CSC, Inc. from 2004 to 2005 and as a Vice President-Administration at Clinishare Pharmacy, Inc. He holds an MBA from the University of Michigan and undergraduate degrees from the National & Kapodistrian University of Athens and King's College London. |
| Eric J. Topol |
Eric J. Topol is the founder of The Gary & Mary West Health Institute (founded in 2009), Molecular Stethoscope, Inc. (founded in 2015), and West Health Institute (founded in 2009). He is also the founder of Cleveland Clinic Lerner College of Medicine. Dr. Topol's current job(s) include Vice Chairman at Gary & Mary West Wireless Health Institute (since 2009), Independent Director at DexCom, Inc. (since 2009), Director at National Institutes of Health, Director at Scripps Translational Science Institute (since 2007), and Executive VP & Professor-Molecular Medicine at The Scripps Research Institute (since 2009). Dr. Topol's former job(s) include Director at Sotera Wireless, Inc., Independent Director at Philips Image Guided Therapy Corp. (2011-2014), Independent Director at MyoKardia, Inc. (2016-2017), Director at California Healthcare Institute, Director at Cypher Genomics, Inc., Professor-Genetics at Case Western Reserve University, Professor at the University of Michigan (1985-1991), and Chief Academic Officer at Scripps Health. Dr. Topol's education history includes an undergraduate degree from the University of Virginia (1975) and a doctorate degree from the University of Rochester Medical Center (1979). |
| Bridgette P. Heller |
Bridgette P. Heller is the founder of Heller Associates, Inc. (founded in 2004) and the Shirley Proctor Puller Foundation (founded in 2019). She holds the title of Managing Partner at Heller Associates, Inc. and was previously the Chief Executive Officer & Director at the Shirley Proctor Puller Foundation. In her current roles, Ms. Heller is the Director at Newman's Own Foundation (since 2021), Independent Non-Executive Director at Novartis AG (since 2020), Independent Director at DexCom, Inc. (since 2019), Director at Newman's Own, Inc. (since 2020), Director at Market Track LLC (since 2021), Independent Director at Aramark (since 2021), Director at Integral Ad Science, Inc., Independent Director at Integral Ad Science Holding Corp. (since 2021), Trustee at Northwestern University, and Trustee at Northwestern University Clinical & Translational Sciences Inst. Ms. Heller's former positions include Chief Executive Officer at Chung's Foods, Inc. (2003-2004), Chairman at Girls, Inc. (2008-2012), Independent Director at Tech Data Corp. (2016-2020), Director at The ADT Security Corp. (2012-2016), Director at PCA International, Inc. (1998-2005), President-Baby Global Business Unit at Johnson & Johnson (2007-2010), President-Consumer Care & Executive VP at Merck & Co., Inc. (2010-2015), President-Nutricia & Executive Vice President at Danone SA (2016-2019), Executive Vice President & GM-Coffee Division at Mondelez International, Inc. (1985-2002), EVP & GM-North American Coffee Portfolio at Kraft Foods Group, Inc. (1985-2002), President & Executive Vice President at Nutricia Holdings Plc (2016-2019), and Executive VP & President-Specialized Nutrition at Danone Nederland BV (2017-2019). She was also the President at Merck-Consumer Care (2010-2015). Ms. Heller's education includes an undergraduate degree from Northwestern University and an MBA from Kellogg School of Management (conferred in 1985). |
| Barbara E. Kahn |
Barbara E. Kahn currently works at DexCom, Inc., as Independent Director from 2011, Latin Builders Association, as Director from 2010, The Marketing Science Institute, as Executive Trustee, The Wharton School of the University of Pennsylvania, as Professor-Marketing from 2011, The Association For Consumer Research, as President, and Journal of Consumer Research, Inc., as President-Policy Board. Dr. Kahn also formerly worked at Jay H. Baker Retailing Center, as Director from 2011 to 2017, the University of Miami, as Dean & Professor-Marketing, and the University of Miami School of Business, as Professor-Marketing from 2007 to 2011. Dr. Kahn received her undergraduate degree from Rochester Christian University and graduate degree, Masters Business Admin degree, and doctorate degree from The Trustees of Columbia University in The City of New York. |
| Richard Alexander Collins |
Richard Alexander Collins is an Independent Director at DexCom, Inc. since 2017. He was the Chief Executive Officer and Chairman at Golden Rule Insurance Co. and Golden Rule Financial Corp. from 2005 to 2012. He also served as President & Director at Mid Atlantic Medical Services LLC and Oxford Health Plans LLC. He was a Director at National Association of Corporate Directors, The Nature Conservancy In Indiana, The Council for Affordable Health Insurance, and Fairbanks Addiction Treatment & Recovery Center. He was the President & Director at UnitedHealthcare Insurance Company of New York and President-Individual Line at UnitedHealth Group, Inc. from 2005 to 2012. He completed his undergraduate degree from Maine Maritime Academy. |
| Kyle J. Malady |
Kyle J. Malady is currently the Group CEO-Verizon Business & Executive VP at Verizon Communications, Inc. He is also the Group Chief Executive Officer at Verizon Business Global LLC and an Independent Director at DexCom, Inc. Previously, he worked as a Director at Nitronex LLC, Vice President-Technology Development at Verizon Wireless, Inc., and as a Principal at Nynex Mobile Communications. He completed his undergraduate degree at the University of Bridgeport and holds an MBA from The Leonard N Stern School of Business. |
| Rimma Driscoll |
Rimma Driscoll is currently an Independent Director at DexCom, Inc. and a Director at Pumpkin Insurance Services, Inc. She previously held the position of EVP, Head-Global Strategy & Business Development at Zoetis, Inc. and is currently a Trustee at Licensing Executives Society. Ms. Driscoll completed her undergraduate degree at Bowling Green State University and holds an MBA from Williams College of Business. |
| Karen M. Dahut |
Karen M. Dahut is an Independent Director at DexCom, Inc., a Director at The National Air & Space Museum, and a Director at EisnerAmper LLP. She is also a Director at Booz Allen Hamilton Engineering Holding Co. LLC and a Trustee at Stone Ridge School of The Sacred Heart. Previously, she served as an Independent Director at Tech Data Corp. from 2017 to 2020. She was also an Executive Vice President at Booz Allen Hamilton Holding Corp. from 2013 to 2018 and an Executive Vice President & Senior Partner at Booz Allen Hamilton, Inc. from 2020 to 2022. Additionally, she was a Member of the Northern Virginia Technology Council from 2010 to 2012 and a Principal at the United States Navy (District of Columbia). Ms. Dahut received her undergraduate degree from Mount Saint Mary's University in 1985 and her graduate degree from USC Viterbi School of Engineering in 1988. |
